Cargando…

Role of CD133/NRF2 Axis in the Development of Colon Cancer Stem Cell-Like Properties

Cancer stem cells (CSCs) exhibit intrinsic therapy/stress resistance, which often cause cancer recurrence after therapy. In this study, we investigated the potential relationship between the cluster of differentiation (CD)-133, a CSC marker of colon cancer, and nuclear factor erythroid 2-like 2 (NFE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jimin, Kim, Seung Ki, Hallis, Steffanus Pranoto, Choi, Bo-Hyun, Kwak, Mi-Kyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825377/ https://www.ncbi.nlm.nih.gov/pubmed/35155201 http://dx.doi.org/10.3389/fonc.2021.808300

Ejemplares similares

Association of NRF2 with HIF-2α-induced cancer stem cell phenotypes in chronic hypoxic condition
por: Hallis, Steffanus Pranoto, et al.
Publicado: (2023)

Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells
por: Lee, Sujin, et al.
Publicado: (2019)

Emerging Role of NRF2 Signaling in Cancer Stem Cell Phenotype
por: Hallis, Steffanus P., et al.
Publicado: (2023)

High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance
por: Ryoo, In-geun, et al.
Publicado: (2018)

CD133-regulated nucleophosmin expression in human colon cancer cells
por: Kim, Kun, et al.
Publicado: (2014)

High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling
por: Kim, Donghyeok, et al.
Publicado: (2018)

HOTAIRM1 Promotes Malignant Progression of Transformed Fibroblasts in Glioma Stem-Like Cells Remodeled Microenvironment via Regulating miR-133b-3p/TGFβ Axis
por: Wang, Haiyang, et al.
Publicado: (2021)

A comprehensive promoter landscape identifies a novel promoter for CD133 in restricted tissues, cancers, and stem cells
por: Sompallae, Ramakrishna, et al.
Publicado: (2013)

CD133(+)CD24(lo) defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype
por: Paschall, Amy V., et al.
Publicado: (2016)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

CD133, Stem Cells, and Cancer Stem Cells: Myth or Reality?
por: Yu, Xiazhen, et al.
Publicado: (2011)

THE CD133-POSITIVE COLON CANCER CELL PHENOTYPE IS MORE INTERACTIVE WITH THE TUMOR MICROENVIRONMENT COMPARED TO CD133-NEGATIVE CELL
por: Chao, Celia, et al.
Publicado: (2011)

DNA alterations in Cd133+ and Cd133- tumour cells enriched from intra-operative human colon tumour biopsies
por: Cervantes-Madrid, Diana, et al.
Publicado: (2017)

Effect of Redox Modulating NRF2 Activators on Chronic Kidney Disease
por: Choi, Bo-hyun, et al.
Publicado: (2014)

Involvement of NRF2 Signaling in Doxorubicin Resistance of Cancer Stem Cell-Enriched Colonospheres
por: Ryoo, In-geun, et al.
Publicado: (2016)

Polymorphisms of the stem cell marker gene CD133 are associated the clinical outcome in a cohort of Chinese non-small cell lung cancer patients
por: Liu, Qing-Feng, et al.
Publicado: (2017)

CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells
por: Barrantes-Freer, Alonso, et al.
Publicado: (2015)

The Prognostic Value of CD133 in Predicting the Relapse and Recurrence Pattern of High-Grade Gliomas on MRI: A Meta-Analysis
por: Abdoli Shadbad, Mahdi, et al.
Publicado: (2021)

Activation of NRF2 by p62 and proteasome reduction in sphere-forming breast carcinoma cells
por: Ryoo, In-geun, et al.
Publicado: (2015)

Mesenchymal stem cell-like properties of CD133(+) glioblastoma initiating cells
por: Pavon, Lorena Favaro, et al.
Publicado: (2016)

Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective
por: Kleinlützum, Dina, et al.
Publicado: (2017)

Endothelial Cell-Derived TGF-β Promotes Epithelial-Mesenchymal Transition via CD133 in HBx-Infected Hepatoma Cells
por: Rawal, Preety, et al.
Publicado: (2019)

Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells
por: Sahlberg, Sara Häggblad, et al.
Publicado: (2014)

Prospectively Isolated Cancer-Associated CD10(+) Fibroblasts Have Stronger Interactions with CD133(+) Colon Cancer Cells than with CD133(−) Cancer Cells
por: Cui, Lin, et al.
Publicado: (2010)

Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer
por: Chen, Wei-Ching, et al.
Publicado: (2015)

Enhanced Expression of ABCB1 and Nrf2 in CD133-Positive Cancer Stem Cells Associates with Doxorubicin Resistance
por: Goto, Shinji, et al.
Publicado: (2020)

Radioimmunotherapy for CD133(+) colonic cancer stem cells inhibits tumor development in nude mice
por: Weng, Dinghu, et al.
Publicado: (2017)

The Novel lncRNA RP9P Promotes Colorectal Cancer Progression by Modulating miR-133a-3p/FOXQ1 Axis
por: Jin, Zhichao, et al.
Publicado: (2022)

Response to Stress in Early Tumor Colonization Modulates Switching of CD133-Positive and CD133-Negative Subpopulations in a Human Metastatic Colon Cancer Cell Line, SW620
por: Hsu, Chih-Sin, et al.
Publicado: (2013)

Potential Role of CD133 Expression in the Susceptibility of Human Liver Cancer Stem-Like Cells to TRAIL
por: Lee, Su-Hoon, et al.
Publicado: (2016)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Autocrine interleukin-23 promotes self-renewal of CD133(+) ovarian cancer stem-like cells
por: Wang, Dan, et al.
Publicado: (2016)

Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?
por: Behrooz, Amir Barzegar, et al.
Publicado: (2021)

CD133 Positive Embryonal Rhabdomyosarcoma Stem-Like Cell Population Is Enriched in Rhabdospheres
por: Walter, Dagmar, et al.
Publicado: (2011)

CircKEAP1 Suppresses the Progression of Lung Adenocarcinoma via the miR-141-3p/KEAP1/NRF2 Axis
por: Wang, Yanbo, et al.
Publicado: (2021)

Elevated expression of Nrf2 mediates multidrug resistance in CD133(+) head and neck squamous cell carcinoma stem cells
por: Lu, Bao-Cai, et al.
Publicado: (2016)

Omega-3 Eicosapentaenoic Acid Decreases CD133 Colon Cancer Stem-Like Cell Marker Expression While Increasing Sensitivity to Chemotherapy
por: De Carlo, Flavia, et al.
Publicado: (2013)

The Sensitivity of Cancer Cells to Pheophorbide a-Based Photodynamic Therapy Is Enhanced by NRF2 Silencing
por: Choi, Bo-hyun, et al.
Publicado: (2014)

Expression and Prognostic Significance of Stem Cell Marker CD133 in Survival Rate of Patients with Colon Cancer
por: Ehteram, Hassan, et al.
Publicado: (2022)

Thrombospondin-1 Receptor CD47 Overexpression Contributes to P-Glycoprotein-Mediated Multidrug Resistance Against Doxorubicin in Thyroid Carcinoma FTC-133 Cells
por: Courageot, Marie-Pierre, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bmft3mp05akjvprm4s5t98kaf4